NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 07/10/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization816.89 mln
Float235 mln
Earnings Date08/04/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-1.91
Caution advised
1-Year Forecast
3.20
Fairly priced
Relative Strength
53
/ 100
Slightly ahead
Debt / Equity
-0.82
Negative equity
Pre-Tax Margin
18%
Healthy margin
Business Description
Esperion Therapeutics is a Michigan-based drug company focused on helping adults manage high LDL cholesterol, commonly known as "bad" cholesterol. Its main products ? NEXLETOL, NEXLIZET, NILEMDO, and NUSTENDI ? are daily oral tablets that lower cholesterol and reduce the risk of heart disease without using statins. The company works with several partners, including Daiichi Sankyo and Otsuka Pharmaceutical, to bring these treatments to patients in the United States and beyond.
